Odds of Bringing Therapeutic Drugs to Market Increase with Collaboration
One of the most tragic inherited red blood cell disorders, to which mostly children are vulnerable, is sickle cell anemia — a condition in which…
Blog
Solution to Low-Cost, High Quality Drugs and Therapies Lies in Research-Sharing
Several thoughtful solutions to the high cost of consumer therapeutic drugs have been proposed in recent years, including Thomas Pogge’s proposition for the Health Impact…
Bioresearch Collaboration Will Speed Development of New Therapies and Mitigate High Drug Prices
This fall, Open Therapeutics (OT) expects to debut an elegant platform that will allow scientists and researchers to collaborate on all aspects of Bioresearch and…
Breaking Down Silos
After seven years of developing and attracting therapeutic technologies, Open Therapeutics is giving them away to the global community, for free, in late 2016. The…
The Science of Childhood Cancer
An Introduction to the Science of Cancer educational video of pediatric cancers, by Timothy P. Cripe, MD, PhD, Open Therapeutics’ Viral Oncolytics Advisor and Chief of…
Immunotherapy – “Most Exciting Development in Cancer Treatment in Years”
Immunotherapy has been referred to as the “most exciting development in cancer treatment in years” (Guardian, 2015). When treatments such as chemotherapy seem to have…
